Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration

NCT03324061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Fulvestrant for Injectable Suspension
DRUG: Faslodex (Reference)

Sponsor

Eagle Pharmaceuticals, Inc.